首页> 外文期刊>World journal of gastroenterology : >Stable knockdown of heparanase expression in gastric cancer cells in vitro.
【24h】

Stable knockdown of heparanase expression in gastric cancer cells in vitro.

机译:体外肝癌细胞中乙酰肝素酶表达的稳定敲低。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To develop short hairpin RNA (shRNA) against heparanase, and to determine its effects on heparanase expression and the malignant characteristics of gastric cancer cells. METHODS: Heparanase-specific shRNA was constructed and transferred into cultured the gastric cancer cell line SGC-7901. Stable subclonal cells were screened by G418 selection. Heparanase expression was measured by reverse transcriptase-polymerase chain reaction (RT-PCR), real-time quantitative PCR and Western blotting. Cell proliferation was detected by 2-(4, 5-dimethyltriazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) colorimetry and colony formation assay. The in vitro invasiveness and metastasis of cancer cells were measured by cell adhesion assay, wound healing assay and matrigel invasion assay. The angiogenesis capabilities of cancer cells were measured by tube formation of endothelial cells. RESULTS: Stable transfection of heparanase-specific shRNA, but not of scrambled shRNA and mock vector, resulted in reduced mRNA and protein levels of heparanase. The shRNA-mediated knockdown of heparanase did not affect the cellular proliferation of SGC-7901 cells. However, the in vitro invasiveness and metastasis of cancer cells were decreased after knockdown of heparanase. Moreover, transfection of heparanase-specific shRNA decreased the in vitro angiogenesis capabilities of SGC-7901 cells. CONCLUSION: Stable knockdown of heparanase can efficiently decrease the invasiveness, metastasis and angiogenesis of human gastric cancer cells. In contrast, stable knockdown of heparanase does not affect the cell proliferation.
机译:目的:开发针对肝素酶的短发夹RNA(shRNA),并确定其对肝素酶表达和胃癌细胞恶性特征的影响。方法:构建肝素酶特异性shRNA并转移至培养的胃癌细胞系SGC-7901中。通过G418选择筛选稳定的亚克隆细胞。肝素酶表达通过逆转录聚合酶链反应(RT-PCR),实时定量PCR和Western印迹法进行测量。通过2-(4,5-二甲基三唑-2-基)-2,5-二苯基溴化四唑(MTT)比色法和集落形成测定法检测细胞增殖。通过细胞粘附测定,伤口愈合测定和基质胶侵袭测定来测量癌细胞的体外侵袭和转移。通过内皮细胞的管形成来测量癌细胞的血管生成能力。结果:稳定转染乙酰肝素酶特异的shRNA,而不是混乱的shRNA和模拟载体,导致乙酰肝素酶的mRNA和蛋白水平降低。 shRNA介导的乙酰肝素酶的敲低不影响SGC-7901细胞的细胞增殖。然而,肝素酶敲低后,癌细胞的体外侵袭和转移减少。此外,肝素酶特异性shRNA的转染降低了SGC-7901细胞的体外血管生成能力。结论:稳定的乙酰肝素酶敲除可以有效降低人胃癌细胞的侵袭,转移和血管生成。相反,乙酰肝素酶的稳定敲低不影响细胞增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号